MMSI

Merit Medical Systems, Inc. (MMSI) | Rumor.io

Merit Medical Systems

MMSI

Attention (50-day avg)0%

Attention rank (50-day avg)#3,845

Bullish sentiment (50-day avg)100%

Price to earnings ratio36

Market capitalization5.2B

Earnings per share2.42

Dividend yield (TTM)—

Revenue (annual)1.5B

Net income (annual)128.5M

Social

What share of all stock conversation is about MMSI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Feb 24

Merit Medical Systems, Inc. ($MMSI) reported Q4 2025 earnings with record margins, but decelerating 2026 growth outlook.
The company beat earnings estimates with adjusted EPS of $1.04, up 11.83% YoY, and revenue of $393.9M, up 10.92% YoY.
Merit Medical Systems anticipates total revenue for fiscal year 2026 to be $1.61B to $1.63B, representing 6%-8% year-over-year growth on a reported basis.

Generated by AI

Sentiment

Of the messages about MMSI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.89% +71.89
Bearish	—	—	—	3.11% -71.89

Topics

Of the messages about MMSI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	40.48%
Earnings	—	—	—	7.94%
Announcements	—	—	—	46.83%
Controversies	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	4.76%

Earnings· Oct 25

Merit Medical Systems, Inc. reported FQ3 earnings of 32c EPS and $179.34M in revenues.
The company's earnings were in line with the Estimize EPS consensus but missed the Estimize Revenue consensus by $4.57M.
Merit Medical updated its FY17 guidance to $1.23-1.28 EPS and revenue guidance to $722-727 million.

Analysts· Feb 25

Raymond James cut Merit Medical Systems' price target to $72.00, maintaining an Outperform rating.
Needham maintained a Buy rating for Merit Medical Systems, lowering the price target to $73.00 from $83.00.
Barrington Research raised Merit Medical Systems' price target to $82.00, from $78.00.

Announcements· Sep 17

Merit Medical Systems, Inc. (MMSI) has signed an agreement to purchase Cook Medical's lead management portfolio for approximately $210 million in cash.
The acquisition is expected to add around $40 million in revenue annually, starting from fiscal year 2025, with a growth profile serving an underpenetrated global lead management market.
Merit Medical has also lowered its FY24 EPS guidance to $3.25-$3.34 and raised its revenue view to $1.339B-$1.351B, with the acquisition projected to contribute to these changes.

Generated by AI

Community

Of the messages about MMSI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	14.9%
Newcomers	—	—	—	85.1%

Regulars· Oct 27

$MMSI's Q3 2023 EPS surged 62.96%, outperforming its industry, while revenue grew 9.759%.

Newcomers· Sep 17

Merit Medical Systems, Inc. has lowered its FY24 EPS guidance to $3.25-$3.34 from $3.27-$3.35.
The company has raised its FY24 revenue view to $1.339B-$1.351B from $1.335B-$1.345B.
Merit Medical has signed an agreement to purchase the lead management portfolio from Cook Medical.

Generated by AI

SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences: The Wells Fargo 2026 Healthcare Conference, which is being held in Boston, MA from September 8-10, 2026. Management is scheduled to participate in a fireside chat on Thursday, September 10th at 8:45 a.m. Eastern Time. The Baird 2026 Global Healthcare

26d agoYahoo Finance

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.

27d agofinance.yahoo.com

How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition

In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades of global manufacturing and supply chain experience from SkinHealth Systems, Avantor, Medtronic, and Honeywell, while long-time operations leader Mr. Peterson shifted to a Senior Advisor role through March 2027 to support continuity. This leadership transition highlights Merit's focus on strengthening global operations and supply chain...

28d agofinance.yahoo.com

Merit Medical Systems (MMSI) Names New Operations Chief As Fair Value Stays In Focus

Why this leadership change at Merit Medical Systems matters for investors Merit Medical Systems (MMSI) recently announced that Sheri Lewis will become Executive Vice President of Global Operations on August 31, 2026, with long time operations leader Mr. Peterson shifting to a Senior Advisor role. For you as an investor, this type of operational leadership change can influence how effectively the company runs its global manufacturing footprint and manages costs. It can also shape how resilient...

28d agofinance.yahoo.com

1 Surging Stock with Exciting Potential and 2 Facing Challenges

Detailed price information for Chord Energy Corp (CHRD-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Also Discussed

Investors talking about MMSI also mention

#	Name	Attention
1	Delek Logistics Partners L.P.DKL	0%new
2	Nova Ltd. Ordinary SharesNVMI	0%new
3	Cactus Inc. Class A Common StockWHD	0%0
4	Qorvo Inc.QRVO	0%0
5	Valley National Bancorp Common StockVLY	0%new
6	BioLife Solutions Inc.BLFS	0%0
7	BRP Inc. Subordinate Voting SharesDOOO	0%0
8	Adient plcADNT	0%new
9	Interface, Inc.TILE	0%new
10	Cirrus Logic Inc.CRUS	0%0

Merit Medical Systems, Inc.

Healthcare
Medical Instruments & Supplies

Merit Medical Systems, Inc. is a medical device company that develops, manufactures, and markets disposable products used in interventional, diagnostic, and therapeutic procedures. Merit Medical Systems, Inc. serves a wide range of clinical specialties through its Cardiovascular and Endoscopy segments, with offerings that support cardiology, radiology, oncology, critical care, gastroenterology, pulmonology, and thoracic surgery. Its product portfolio includes access devices, drainage and embolotherapy tools, guide wires, balloon dilators, inflation devices, procedure kits, hemostasis solutions, and other single-use technologies designed for minimally invasive care. The company also provides products used in interventional oncology, spine procedures, cardiac rhythm management, electrophysiology, and cardiovascular critical care. Headquartered in South Jordan, Utah, Merit Medical Systems, Inc. plays a role in supplying hospitals, clinicians, and procedure centers with specialized tools for modern medical interventions.

Website

Location

1600 West Merit Parkway

South Jordan, UT, 84095

United States

Social

What share of all stock conversation is about MMSI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Feb 24

Merit Medical Systems, Inc. ($MMSI) reported Q4 2025 earnings with record margins, but decelerating 2026 growth outlook.
The company beat earnings estimates with adjusted EPS of $1.04, up 11.83% YoY, and revenue of $393.9M, up 10.92% YoY.
Merit Medical Systems anticipates total revenue for fiscal year 2026 to be $1.61B to $1.63B, representing 6%-8% year-over-year growth on a reported basis.

Generated by AI

Sentiment

Of the messages about MMSI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.89% +71.89
Bearish	—	—	—	3.11% -71.89

Topics

Of the messages about MMSI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	40.48%
Earnings	—	—	—	7.94%
Announcements	—	—	—	46.83%
Controversies	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	4.76%

Earnings· Oct 25

Merit Medical Systems, Inc. reported FQ3 earnings of 32c EPS and $179.34M in revenues.
The company's earnings were in line with the Estimize EPS consensus but missed the Estimize Revenue consensus by $4.57M.
Merit Medical updated its FY17 guidance to $1.23-1.28 EPS and revenue guidance to $722-727 million.

Analysts· Feb 25

Raymond James cut Merit Medical Systems' price target to $72.00, maintaining an Outperform rating.
Needham maintained a Buy rating for Merit Medical Systems, lowering the price target to $73.00 from $83.00.
Barrington Research raised Merit Medical Systems' price target to $82.00, from $78.00.

Announcements· Sep 17

Merit Medical Systems, Inc. (MMSI) has signed an agreement to purchase Cook Medical's lead management portfolio for approximately $210 million in cash.
The acquisition is expected to add around $40 million in revenue annually, starting from fiscal year 2025, with a growth profile serving an underpenetrated global lead management market.
Merit Medical has also lowered its FY24 EPS guidance to $3.25-$3.34 and raised its revenue view to $1.339B-$1.351B, with the acquisition projected to contribute to these changes.

Generated by AI

Community

Of the messages about MMSI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	14.9%
Newcomers	—	—	—	85.1%

Regulars· Oct 27

$MMSI's Q3 2023 EPS surged 62.96%, outperforming its industry, while revenue grew 9.759%.

Newcomers· Sep 17

Merit Medical Systems, Inc. has lowered its FY24 EPS guidance to $3.25-$3.34 from $3.27-$3.35.
The company has raised its FY24 revenue view to $1.339B-$1.351B from $1.335B-$1.345B.
Merit Medical has signed an agreement to purchase the lead management portfolio from Cook Medical.

Generated by AI

Merit Medical Systems

Social

Feb 24

Sentiment

Topics

Earnings· Oct 25

Analysts· Feb 25

Announcements· Sep 17

Community

Regulars· Oct 27

Newcomers· Sep 17

News

Merit Medical at Wells Fargo conference: strategic review deepens

Merit Medical to Participate in Upcoming Investors Conferences in September

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition

Merit Medical Systems (MMSI) Names New Operations Chief As Fair Value Stays In Focus

1 Surging Stock with Exciting Potential and 2 Facing Challenges

Also Discussed

Merit Medical Systems, Inc.

Company Information

Location

Social

Feb 24

Sentiment

Topics

Earnings· Oct 25

Analysts· Feb 25

Announcements· Sep 17

Community

Regulars· Oct 27

Newcomers· Sep 17

News

Merit Medical at Wells Fargo conference: strategic review deepens

Merit Medical to Participate in Upcoming Investors Conferences in September

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition

Merit Medical Systems (MMSI) Names New Operations Chief As Fair Value Stays In Focus

1 Surging Stock with Exciting Potential and 2 Facing Challenges

Also Discussed